The 15-15 rule for treating low blood sugar safely

The 15-15 rule is the ADA-recommended protocol for treating mild to moderate hypoglycemia: consume 15 grams of fast-acting carbohydrate, wait 15 minutes, then recheck blood glucose. If glucose remains below 70 mg/dL, repeat. If glucose has risen above 70 mg/dL, eat a small snack with protein and complex carbohydrate to stabilise. That is the whole rule — and it is deceptively simple. Where people go wrong is in the execution: they over-treat (eating 60 grams of carbohydrate when 15 is sufficient) and create a post-hypo rebound spike, or they use the wrong fast-acting carbohydrate source (a chocolate bar, which has enough fat to slow glucose absorption when speed matters), or they skip the recheck and assume 15 minutes was enough. Per ADA Standards of Care 2024 §6.4, glucose tablets and gels are the preferred treatment sources because their carbohydrate content is precise and their absorption is reliably fast. Getting this protocol exactly right is not a minor detail — it prevents the anxiety-driven over-treatment cycle that keeps people running high “just to be safe” and ultimately wrecks long-term A1C.

Why 15 grams — the pharmacokinetics of glucose treatment

The 15-gram dose was not selected arbitrarily. It represents the amount of pure oral glucose required to reliably raise blood glucose by 30–45 mg/dL in a 70 kg adult within 15 minutes, based on pharmacokinetic studies of oral glucose absorption conducted in the 1980s and validated repeatedly since.¹ The effect is dose-proportional: 10 grams raises glucose by approximately 20–30 mg/dL, 20 grams by approximately 40–60 mg/dL. The 15-gram standard represents a calibrated middle ground — enough to bring a 55 mg/dL reading safely above 70 mg/dL without producing an overcorrection spike that runs glucose to 180–200 mg/dL and creates its own management problem.

The absorption mechanism explains why the source of those 15 grams matters. Oral glucose enters the portal circulation through two main routes: passive paracellular transport and active SGLT1-mediated transport across the intestinal epithelium. Glucose tablets and solutions provide pure D-glucose, which crosses the duodenal and jejunal mucosa within 5–10 minutes of ingestion and produces a measurable plasma glucose rise within 10–15 minutes. A finger-stick glucometer reads the capillary blood glucose response a few minutes after that — which is why the 15-minute recheck window is the minimum, not the maximum, time to wait.²

Body weight matters at the extremes. A 50 kg adult with Type 1 diabetes may find 15 grams raises glucose by 50–60 mg/dL, while a 120 kg adult with insulin-resistant Type 2 diabetes may see only a 20–25 mg/dL rise from the same dose. The ADA acknowledges this variability and notes that children require approximately 0.3 g/kg body weight rather than a flat 15-gram dose — a 30 kg child needs about 9 grams, not 15.¹ For adults with significant insulin resistance, a second 15-gram dose at the 15-minute mark may be necessary if glucose has not crossed 70 mg/dL, but the correct response is to recheck first and then decide — not to double-dose preemptively.

The physiological precision of the 15-gram dose is one reason the ADA strongly prefers glucose tablets over food-based alternatives: a glucose tablet reliably delivers its stated dose. A “handful of crackers” does not.

Approved 15-gram carbohydrate sources — fast vs slow

The defining characteristic of a suitable treatment source is absorption speed, not carbohydrate content alone. Fat, protein, and fiber all slow gastric emptying and delay glucose absorption — which is exactly the property you do not want when you are trying to raise blood glucose rapidly.³

Approved fast-acting sources (15 g carbohydrate):

• Glucose tablets: 4 tablets = 16 g (most brands; check the label — dose is precise)
• Glucose gel: 1 standard sachet = 15 g (convenient for exercise or travel)
• Regular (not diet) soda: 150 ml of standard cola or lemonade = approximately 15 g
• Orange juice: 125–150 ml = approximately 15 g carbohydrate
• Honey: 1 tablespoon = 17 g (dissolves quickly; avoid if aspiration risk is present)
• Sugar dissolved in water: 3–4 teaspoons in 150 ml water

Non-approved sources that will fail you:

• Chocolate: a 30 g bar may contain 15 g carbohydrate, but the fat content (8–10 g) delays gastric emptying by 20–30 minutes. Glucose absorption is meaningfully slowed; you may wait 30 minutes to see a response and then double-dose unnecessarily.³
• Granola bars, protein bars, crackers: the fiber, fat, and protein matrix slows absorption. Satiety and calorie adequacy are fine for the post-treatment snack; these items do not belong in the acute treatment phase.
• Peanut butter: fat and protein dominate. Will not raise glucose reliably within 15 minutes.
• Full meals: meal-based treatment causes massive carbohydrate overload and a prolonged spike. Reserve meals for the post-stabilisation phase.

Glucose tablets are the clinical gold standard because they are portable, shelf-stable, dose-precise, and taste neutral enough that they do not trigger further eating. Keep a tube in your bag, your desk drawer, your car, and your nightstand. Low blood sugar does not wait for a convenient location.

The 15-minute wait — what happens inside the body

The 15-minute wait is one of the hardest parts of the 15-15 rule. Hypoglycemia produces autonomic symptoms — sweating, trembling, heart pounding, anxiety — that feel like they demand immediate action. The urge to keep eating something more is physiologically and psychologically powerful. Resisting it requires understanding exactly why 15 minutes is the right interval.

After swallowing a glucose tablet, absorption begins in the small intestine within 2–3 minutes. Plasma glucose begins rising 5–10 minutes post-ingestion. Capillary blood glucose, as measured by a finger-stick glucometer, lags plasma glucose by approximately 3–5 minutes because capillary equilibration follows the plasma rise with a brief delay. This means that a finger-stick reading at 5 minutes post-treatment will likely still show a low number even though plasma glucose is already rising — the reading is not wrong, it is simply early.²

Rechecking at 5 minutes and seeing 62 mg/dL when the starting value was 58 mg/dL creates a false sense that treatment is failing. The temptation to consume more carbohydrate at this point is the direct cause of the post-hypo rebound spike. Glucose tablets consumed between minutes 5 and 10 arrive at peak intestinal absorption precisely when the original treatment is starting to produce its full capillary reading. The additive dose produces a glucose of 180–200 mg/dL twenty minutes later — a rebound that causes both symptom discomfort and additional insulin dose complexity.

During the 15-minute wait, the most evidence-based strategy is distraction: keep your hands busy with something other than food. Set a timer for exactly 15 minutes. Sit down if you feel unsteady. If symptoms worsen rather than plateau during the wait — if you feel more confused, cannot maintain sitting posture, or the trembling intensifies rather than stabilising — this signals a deeper low that requires immediate action. But mild symptoms (sweating, hunger, mild anxiety) that are stable are consistent with normal treatment kinetics. Wait the full 15 minutes before deciding the protocol has failed.

When the 15-15 rule needs modification — severe lows and insulin stacking

The standard 15-15 rule is calibrated for Level 1 hypoglycemia (glucose 54–70 mg/dL). Level 2 hypoglycemia (glucose below 54 mg/dL) and scenarios involving active insulin stacking both require protocol modification.¹

Level 2 hypoglycemia (below 54 mg/dL): At this glucose level, cognitive impairment may be beginning. The standard 15-gram dose may produce only a 30 mg/dL rise, leaving glucose still at 55–65 mg/dL after the first cycle. For Level 2 lows, the ADA recommends beginning with 15–20 grams of fast-acting carbohydrate and rechecking at 15 minutes, then repeating with another 15 grams if still below 70 mg/dL. Do not wait a second 15-minute cycle before re-dosing a Level 2 low that has not responded to the first dose — the recheck at 15 minutes is sufficient to guide immediate re-treatment. If glucose is below 54 mg/dL and the person cannot swallow safely, glucagon is the appropriate treatment; oral glucose should never be given to someone who is unconscious or unable to swallow.

Insulin stacking: Stacking occurs when active bolus insulin from a recent mealtime dose has not yet finished its action curve. Rapid-acting insulin analogs (lispro, aspart, glulisine) have action peaks at 1–2 hours and tails extending to 3–4 hours. A hypoglycemia episode during the tail of a bolus requires ongoing glucose support even after the initial 15-15 cycle succeeds in bringing glucose above 70 mg/dL, because the insulin will continue acting and may pull glucose back down. In this scenario, the post-treatment snack (see next section) is not optional — it is essential, and the protein-complex-carb combination should be consumed even if glucose has risen to 85–90 mg/dL.¹

Nocturnal hypoglycemia: Lows during sleep are both more dangerous (the autonomic symptoms that would wake a person are blunted during deep sleep) and more likely to produce severe outcomes. Continuous glucose monitors (CGMs) with low-glucose alarms are the primary protection against undetected nocturnal lows. If a nocturnal low is detected and treated, the post-treatment snack is more important than during daytime, because the person will be returning to sleep and no further monitoring will occur until morning. A 20-gram complex-carbohydrate snack with protein before returning to sleep is the standard recommendation.

Post-treatment snack — preventing the rebound low

Once blood glucose has risen above 70 mg/dL at the 15-minute recheck, the treatment phase is complete. The glucose is stabilising. But the treatment glucose will be metabolised within 45–60 minutes, and if a meal is not imminent, a second glucose dip is likely — particularly in people with Type 1 diabetes who have active basal insulin.

The post-treatment snack targets a different physiological goal from the treatment itself: sustained glucose delivery over 1–2 hours rather than rapid rise. This requires slow-digesting carbohydrate paired with protein:

• 1 slice whole grain bread + 2 tablespoons peanut butter (approximately 15 g complex carb + 8 g protein)
• 6 whole grain crackers + 30 g low-fat cheese (approximately 15 g carb + 7 g protein)
• 125 ml low-fat milk + a small banana (approximately 15–20 g carb + 4 g protein)
• A small bowl (150 g) of yoghurt with no added sugar (approximately 10 g carb + 8 g protein)

The carbohydrate component provides ongoing glucose availability as the initial treatment wears off. The protein component slows gastric emptying moderately and provides amino acids for gluconeogenesis if needed — protein does not raise glucose rapidly, but it sustains it.³

If the next planned meal is within 60 minutes, the post-treatment snack can be abbreviated or skipped entirely — the meal will take its place. If the next meal is more than 90 minutes away, the snack is not optional. The glucose from 15 grams of fast-acting carbohydrate will be completely cleared in under an hour in most people with active insulin; without a bridge snack, a second low is the predictable outcome.

Documenting lows — the data your care team needs

Every hypoglycemia episode is a signal from your diabetes management system that something is not calibrated correctly. The signal is only useful if it is recorded. A care team managing insulin regimens without data is guessing; a care team with a 3-week hypoglycemia log is doing precision medicine.

The minimum data per episode:

1. Date and time of the low
2. Pre-treatment glucose reading (exact number, not “felt low”)
3. What was used as treatment and the exact gram count
4. 15-minute post-treatment glucose reading
5. 30-minute post-treatment glucose reading (useful for assessing rebound)
6. What you had eaten in the preceding 2–4 hours
7. Any unusual activity, illness, or medication change in the preceding 24 hours

Three weeks of this log will typically reveal patterns: nocturnal lows clustering around a specific insulin dose, post-exercise lows 4–6 hours after activity, lows consistently occurring before dinner suggesting too-high afternoon basal. These patterns are not visible without the data, and the adjustments they motivate — basal rate changes, insulin-to-carb ratio adjustments, snack additions — are the interventions that actually prevent the next low rather than just treating it after the fact.¹

Most CGM platforms (Dexcom Clarity, Libre LinkUp, Medtronic CareLink) generate hypoglycemia event reports automatically. If you use a CGM, export the low event log before each care team appointment. If you use finger-stick monitoring, maintain a written or app-based log. Your endocrinologist can review three weeks of low events in five minutes and make targeted regimen changes that reduce future episodes. Without the log, the appointment is a discussion about general patterns rather than a data-driven intervention.

References

1. American Diabetes Association Professional Practice Committee. “Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024.” Diabetes Care 47, Supplement 1 (2024): S111–S125. Section 6.

2. Cryer PE, Axelrod L, Grossman AB, et al. “Evaluation and Management of Adult Hypoglycemic Disorders.” Journal of Clinical Endocrinology & Metabolism 94, no. 3 (2009): 709–728.

3. Sheard NF, Clark NG, Brand-Miller JC, et al. “Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes.” Diabetes Care 27, no. 9 (2004): 2266–2271.

4. Tay J, Luscombe-Marsh ND, Thompson CH, et al. “A Very Low-Carbohydrate, Low–Saturated Fat Diet for Type 2 Diabetes Management.” Diabetes Care 37, no. 11 (2014): 2909–2918.

5. Workgroup on Hypoglycemia, American Diabetes Association. “Defining and Reporting Hypoglycemia in Diabetes.” Diabetes Care 28, no. 5 (2005): 1245–1249.